|![[Search]](https://talks.cam.ac.uk/images/search.gif?1209136071)
|![[A-Z Index]](https://talks.cam.ac.uk/images/az.gif?1209136071)
|![[Contact]](https://talks.cam.ac.uk/images/contact.gif?1209136071)
||![[University of Cambridge]](https://talks.cam.ac.uk/images/identifier2.gif?1209136071){kind=small} |
COOKIES: By using this website you agree that we can place Google Analytics Cookies on your device for performance monitoring. | ![[Talks.cam]](https://talks.cam.ac.uk/images/talkslogosmall.gif?1209136071) |
University of Cambridge > Talks.cam > Department of Pharmacology Seminar Series > PDRA Talks: Nuclear envelope integrity in health and disease | A role for the proton
PDRA Talks: Nuclear envelope integrity in health and disease | A role for the protonAdd to your list(s) Download to your calendar using vCal
If you have a question about this talk, please contact Daniel Paolo Juan. Nuclear envelope integrity in health and disease Dr Anne Janssen University of Cambridge, Department of Pharmacology Biography Anne studied Biotechnology at Wageningen University. After finishing her Masters degree she started her PhD in the lab of Lukas Kapitein (Utrecht University, the Netherlands) working on the generation of inducible tools to study protein aggregation and degradation by the autophagy pathway. During her PhD work she got interested in the nuclear envelope which is why she joined the lab of Delphine Larrieu in 2019 to work on nuclear envelope integrity and premature aging diseases. Initially at CIMR , the lab moved to the department of Pharmacology in 2022. Currently, Anne works on an independent project for which she got a Leverhulme Early Career Fellowship to discover new players in nuclear envelope integrity maintenance. Dr Luke Pattison A role for the proton-sensing GPCR , GPR65 in inflammatory joint pain University of Cambridge, Department of Pharmacology Biography Luke studied Molecular and Cellular Biology at the University of Bath. During his undergraduate degree he undertook a placement at the Monash Institute of Pharmaceutical Sciences in Melbourne, Australia, where he studied the compartmentalised signalling of a G protein-coupled receptor (GPCR) implicated in inflammatory pain. Luke undertook his doctoral research in the Smith lab, submitting his thesis in 2021, which explored the contributions of proton-sensing GPC Rs to inflammatory pain. Luke is continuing in the Smith lab as a postdoctoral researcher working on the Advanced Discovery of Visceral Analgesics via Neuroimmune Targets and the Genetics of Extreme human phenotypes (ADVANTAGE) consortium as part of the MRC Advanced Pain Discovery Platform. Venue: Level 2 Seminar Room Zoom Link: https://cam-ac-uk.zoom.us/j/89184640892?pwd=VnZXbEU4bDdtbkt5MEV2NWt0RUJtUT09 Meeting ID: 891 8464 0892 Passcode: 620598 This talk is part of the Department of Pharmacology Seminar Series series. This talk is included in these lists:
Note that ex-directory lists are not shown. |
Other listsBiology talks Toys are children's words | Choose the first-rate toys to shop for your children Centre of Latin American Studies - lecturesOther talksCritical Points Of Discrete Periodic Operators Negative effective viscosity in strongly stratified turbulence Andrew Robinson on "Vital Signs: What has Semiotics to do with the Origins of Life?" The solar tachocline: An extremely puzzling layer Why it’s important to think about equity, diversity and inclusion when designing, running, analysing and reporting clinical trials BSU Seminar: “Bayesian behavioural-change epidemic models: is your population alarmed?” |
Dr Anne Janssen, Dr Luke Pattison, University of Cambridge, Department of Pharmacology
Friday 08 March 2024, 16:00-17:00